|
1
|
Goodenberger ML and Jenkins RB: Genetics
of adult glioma. Cancer Genet. 205:613–621. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ohgaki H and Kleihues P: Epidemiology and
etiology of gliomas. Acta Neuropathol. 109:93–108. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang F, Huang Q and Zhou LY: Analysis of
the treatment of gliomas with SEC therapy combined with
radiochemotherapy. Eur Rev Med Pharmacol Sci. 19:2400–2405.
2015.PubMed/NCBI
|
|
4
|
Quick A, Patel D, Hadziahmetovic M,
Chakravarti A and Mehta M: Current therapeutic paradigms in
glioblastoma. Rev Recent Clin Trials. 5:14–27. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al European Organisation for Research and Treatment of Cancer
Brain Tumor and Radiotherapy Groups; National Cancer Institute of
Canada Clinical Trials Group: Radiotherapy plus concomitant and
adjuvant temozolomide for glioblastoma. N Engl J Med. 352:987–996.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stupp R, Hegi ME, Mason WP, van den Bent
MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B,
Belanger K, et al European Organisation for Research and Treatment
of Cancer Brain Tumour and Radiation Oncology Groups; National
Cancer Institute of Canada Clinical Trials Group: Effects of
radiotherapy with concomitant and adjuvant temozolomide versus
radiotherapy alone on survival in glioblastoma in a randomised
phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet
Oncol. 10:459–466. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Neyns B, Tosoni A, Hwu WJ and Reardon DA:
Dose-dense temozolomide regimens: Antitumor activity, toxicity, and
immunomodulatory effects. Cancer. 116:2868–2877. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hori YS, Hosoda R, Akiyama Y, Sebori R,
Wanibuchi M, Mikami T, Sugino T, Suzuki K, Maruyama M, Tsukamoto M,
et al: Chloroquine potentiates temozolomide cytotoxicity by
inhibiting mitochondrial autophagy in glioma cells. J Neurooncol.
122:11–20. 2015. View Article : Google Scholar
|
|
9
|
Zhang Y, Wang SX, Ma JW, Li HY, Ye JC, Xie
SM, Du B and Zhong XY: EGCG inhibits properties of glioma stem-like
cells and synergizes with temozolomide through downregulation of
P-glycoprotein inhibition. J Neurooncol. 121:41–52. 2015.
View Article : Google Scholar
|
|
10
|
Sheehan J, Cifarelli CP, Dassoulas K,
Olson C, Rainey J and Han S: Trans-sodium crocetinate enhancing
survival and glioma response on magnetic resonance imaging to
radiation and temozolomide. J Neurosurg. 113:234–239. 2010.
View Article : Google Scholar
|
|
11
|
Park EM and Rosenstein DL: Depression in
adolescents and young adults with cancer. Dialogues Clin Neurosci.
17:171–180. 2015.PubMed/NCBI
|
|
12
|
Lauer AL: Treatment of anxiety and
depression in adolescents and young adults with cancer. J Pediatr
Oncol Nurs. 32:278–283. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Perez-Caballero L, Torres-Sanchez S, Bravo
L, Mico JA and Berrocoso E: Fluoxetine: A case history of its
discovery and preclinical development. Expert Opin Drug Discov.
9:567–578. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kannen V, Marini T, Turatti A, Carvalho
MC, Brandão ML, Jabor VA, Bonato PS, Ferreira FR, Zanette DL, Silva
WA Jr, et al: Fluoxetine induces preventive and complex effects
against colon cancer development in epithelial and stromal areas in
rats. Toxicol Lett. 204:134–140. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Koh SJ, Kim JM, Kim IK, Kim N, Jung HC,
Song IS and Kim JS: Fluoxetine inhibits NF-κB signaling in
intestinal epithelial cells and ameliorates experimental colitis
and colitis-associated colon cancer in mice. Am J Physiol
Gastrointest Liver Physiol. 301:G9–G19. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kannen V, Hintzsche H, Zanette DL, Silva
WA Jr, Garcia SB, Waaga-Gasser AM and Stopper H: Antiproliferative
effects of fluoxetine on colon cancer cells and in a colonic
carcinogen mouse model. PLoS One. 7:e500432012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mun AR, Lee SJ, Kim GB, Kang HS, Kim JS
and Kim SJ: Fluoxetine-induced apoptosis in hepatocellular
carcinoma cells. Anticancer Res. 33:3691–3697. 2013.PubMed/NCBI
|
|
18
|
Lin KL, Chou CT, Cheng JS, Chang HT, Liang
WZ, Kuo CC, Chen IL, Tseng LL, Shieh P, Wu RF, et al: Effect of
fluoxetine on [Ca2+]i and cell viability in OC2 human
oral cancer cells. Chin J Physiol. 57:256–264. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee CS, Kim YJ, Jang ER, Kim W and Myung
SC: Fluoxetine induces apoptosis in ovarian carcinoma cell line
OVCAR-3 through reactive oxygen species-dependent activation of
nuclear factor-kappaB. Basic Clin Pharmacol Toxicol. 106:446–453.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song T, Li H, Tian Z, Xu C, Liu J and Guo
Y: Disruption of NF-κB signaling by fluoxetine attenuates MGMT
expression in glioma cells. Onco Targets Ther. 8:2199–2208.
2015.
|
|
21
|
Cloonan SM and Williams DC: The
antidepressants maprotiline and fluoxetine induce Type II
autophagic cell death in drug-resistant Burkitt's lymphoma. Int J
Cancer. 128:1712–1723. 2011. View Article : Google Scholar
|
|
22
|
Zhou T, Duan J, Wang Y, Chen X, Zhou G,
Wang R, Fu L and Xu F: Fluoxetine synergys with anticancer drugs to
overcome multidrug resistance in breast cancer cells. Tumour Biol.
33:1299–1306. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bijnsdorp IV, Giovannetti E and Peters GJ:
Analysis of drug interactions. Methods Mol Biol. 731:421–434. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma J, Qiu Y, Yang L, Peng L, Xia Z, Hou
LN, Fang C, Qi H and Chen HZ: Desipramine induces apoptosis in rat
glioma cells via endoplasmic reticulum stress-dependent CHOP
pathway. J Neurooncol. 101:41–48. 2011. View Article : Google Scholar
|
|
25
|
Bundeff AW and Woodis CB: Selective
serotonin reuptake inhibitors for the treatment of irritable bowel
syndrome. Ann Pharmacother. 48:777–784. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dharmshaktu P, Tayal V and Kalra BS:
Efficacy of antidepressants as analgesics: A review. J Clin
Pharmacol. 52:6–17. 2012. View Article : Google Scholar
|
|
27
|
Frick LR, Rapanelli M, Arcos ML, Cremaschi
GA and Genaro AM: Oral administration of fluoxetine alters the
proliferation/apoptosis balance of lymphoma cells and up-regulates
T cell immunity in tumor-bearing mice. Eur J Pharmacol.
659:265–272. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Koch GL: The endoplasmic reticulum and
calcium storage. BioEssays. 12:527–531. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Klausner RD and Sitia R: Protein
degradation in the endoplasmic reticulum. Cell. 62:611–614. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu H, Ng BS and Thibault G: Endoplasmic
reticulum stress response in yeast and humans. Biosci Rep.
34:e001182014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Oyadomari S and Mori M: Roles of
CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ.
11:381–389. 2004. View Article : Google Scholar
|
|
32
|
Sano R and Reed JC: ER stress-induced cell
death mechanisms. Biochim Biophys Acta. 1833:3460–3470. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Roos WP, Batista LF, Naumann SC, Wick W,
Weller M, Menck CF and Kaina B: Apoptosis in malignant glioma cells
triggered by the temozolomide-induced DNA lesion
O6-methylguanine. Oncogene. 26:186–197. 2007. View Article : Google Scholar
|
|
34
|
Zhang WB, Wang Z, Shu F, Jin YH, Liu HY,
Wang QJ and Yang Y: Activation of AMP-activated protein kinase by
temozolomide contributes to apoptosis in glioblastoma cells via p53
activation and mTORC1 inhibition. J Biol Chem. 285:40461–40471.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zou Y, Wang Q and Wang W: MutL homolog 1
contributes to temozolomide-induced autophagy via
ataxia-telangiectasia mutated in glioma. Mol Med Rep. 11:4591–4596.
2015.PubMed/NCBI
|
